GenoSolutions, Inc. is an industry leader in early diagnosis of cancer and diseases using genomic data. Genome sequencing has been on an amazing scientific and economic journey for the last three decades. The Human Genome Project began in 1990 with the aim of mapping and sequencing the whole structure of human genome. This bold and daring project took 13 years and a large sum of money, approximately $2.7 billion for the US government, to complete. Since then, the amount of genetic information has multiplied. Consumers get access to genetic tests and even their own genome sequencing data; people can learn about their own genetic information and medical conditions through DNA tests that we provide. GenoSolutions is an exclusively strategic partner of Clinomics, Inc., a leading genomic research company, not only to offer various industries recognized and widely used genetic testing platforms and techniques, but also to provide a family of solutions addressing human health and wellbeing. Our product and service offerings include: • Testing Service: o GenosSystem, o GenoSolution-1, o GenoSolution-10, o Geno-Book, o Geno-CD Prime, o Geno-NIPT • Solutions / Products: o GenoBeauty (personalized cosmetic) o GenoLife (Personalized Supplements) These are the key to “Preventive” and “Precision” Medicine. We strive to be the leader in the Genetics Industry by using our proprietary and state-of-the-art GenoSystem technology with deep machine learning capabilities, in order to mine vast amounts of genetic information for new clues about disease, diagnosis and treatment, and combine the amazing potential of AI and genetics to open the new horizons in healthcare. Currently, we aim to provide highly personalized and curated healthcare solutions to both human beings and animals.